Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

GI drawing
Video
Corey Siegel, MD, and Jessica Salwen-Deremer, PhD, on Sleep Disturbance Among Patients with IBD
11/23/2021
Corey Siegel, MD, and Jessica Salwen-Deremer, PhD, from Dartmouth-Hitchcock Medical Center, discuss the prevalence of sleep disturbances and insomnia among patients with inflammatory bowel disease, and how cognitive behavioral therapy can...
Corey Siegel, MD, and Jessica Salwen-Deremer, PhD, from Dartmouth-Hitchcock Medical Center, discuss the prevalence of sleep disturbances and insomnia among patients with inflammatory bowel disease, and how cognitive behavioral therapy can...
Corey Siegel, MD, and Jessica...
11/23/2021
Advances in Inflammatory Bowel Disease Network
Dr Edward Barnes
Video
Edward Barnes, MD, on Emerging Management of Disorders of the Pouch
11/23/2021
In this video, Dr Barnes discusses the highlights from his presentation on Emerging Management of Disorders of the Pouch from the Advances in Inflammatory Bowel Disease regional meeting on September 25.
In this video, Dr Barnes discusses the highlights from his presentation on Emerging Management of Disorders of the Pouch from the Advances in Inflammatory Bowel Disease regional meeting on September 25.
In this video, Dr Barnes...
11/23/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Aline Charabaty
Conference Coverage
Aline Charabaty, MD, on the Safety of Ustekinumab Among Older Patients With IBD
11/08/2021
Dr Charabaty, from Johns Hopkins School of Medicine, discusses the poster presentation on the study of safety of ustekinumab among patients aged 60 years and older with inflammatory disease, which was shown at the recent American College of...
Dr Charabaty, from Johns Hopkins School of Medicine, discusses the poster presentation on the study of safety of ustekinumab among patients aged 60 years and older with inflammatory disease, which was shown at the recent American College of...
Dr Charabaty, from Johns Hopkins...
11/08/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst
Conference Coverage
Sara Horst, MD, on the Impact of Insurance Delay on Dose Escalation of Subcutaneous Biologics in IBD
11/05/2021
Dr Horst, from Vanderbilt University, reviews the results a study of how a delay of more than 14 days in escalating dosage of biologic treatment can affect outcomes for patients with IBD.
Dr Horst, from Vanderbilt University, reviews the results a study of how a delay of more than 14 days in escalating dosage of biologic treatment can affect outcomes for patients with IBD.
Dr Horst, from Vanderbilt...
11/05/2021
Advances in Inflammatory Bowel Disease Network
acg logo
Conference Coverage
Starting, Switching, and Stopping Therapy for IBD
11/04/2021
Dr Christina Ha, from Cedars-Sinai, moderated a discussion at the ACG Scientific Meeting with Dr Raymond Cross, from the University of Maryland, and Dr Bincy Abraham, from Houston Methodist, about beginning IBD therapy, changing therapeutic...
Dr Christina Ha, from Cedars-Sinai, moderated a discussion at the ACG Scientific Meeting with Dr Raymond Cross, from the University of Maryland, and Dr Bincy Abraham, from Houston Methodist, about beginning IBD therapy, changing therapeutic...
Dr Christina Ha, from...
11/04/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Seema Patil, MD
ACG Insights
Seema Patil, MD, on Optimal and Future Use of IL-12/23 Inhibitors in IBD
10/20/2021
Dr Patil, from the University of Maryland School of Medicine, discusses the optimal and future uses of IL-12/23 inhibitors for the management of inflammatory bowel disease.
Dr Patil, from the University of Maryland School of Medicine, discusses the optimal and future uses of IL-12/23 inhibitors for the management of inflammatory bowel disease.
Dr Patil, from the University of...
10/20/2021
Advances in Inflammatory Bowel Disease Network
Adam Cheifetz, MD, on Managing Severe Ulcerative Colitis
Videos
Adam Cheifetz, MD, on Managing Severe Ulcerative Colitis
10/19/2021
Dr Cheifetz, from Beth Israel Deaconess Medical Center in Boston, spoke about the treatment options available for patients with severe ulcerative colitis, from medical management to surgery at the recent Interdisciplinary Autoimmune Summit.
Dr Cheifetz, from Beth Israel Deaconess Medical Center in Boston, spoke about the treatment options available for patients with severe ulcerative colitis, from medical management to surgery at the recent Interdisciplinary Autoimmune Summit.
Dr Cheifetz, from Beth Israel...
10/19/2021
Advances in Inflammatory Bowel Disease Network
Uni Wong
Conference Coverage
Uni Wong, MD, on Perianal Crohn Disease
09/25/2021
Dr Wong, from the University of Maryland, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting on caring for patients with perianal Crohn disease.
Dr Wong, from the University of Maryland, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting on caring for patients with perianal Crohn disease.
Dr Wong, from the University of...
09/25/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on the Hospitalized Patient With Ulcerative Colitis
09/25/2021
In this video Dr Regueiro, chair of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation on caring for the hospitalized patient with ulcerative colitis from the AIBD regional meeting on September 11.
In this video Dr Regueiro, chair of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation on caring for the hospitalized patient with ulcerative colitis from the AIBD regional meeting on September 11.
In this video Dr Regueiro, chair...
09/25/2021
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on S1P Inhibitors: Considerations for the ‘New Kid’ on the Block
09/25/2021
In this video Dr Regueiro, chair of the Digestive Disease and Surgery Institute at Cleveland Clinic, talks about the uses of the newest therapy approved for ulcerative colitis, S1P inhibitors, which he discussed at the AIBD regional meeting...
In this video Dr Regueiro, chair of the Digestive Disease and Surgery Institute at Cleveland Clinic, talks about the uses of the newest therapy approved for ulcerative colitis, S1P inhibitors, which he discussed at the AIBD regional meeting...
In this video Dr Regueiro, chair...
09/25/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Shows Efficacy Among Biologic-Exposed Patients With Crohn’s Disease
09/24/2024
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed...
09/24/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/29/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/29/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jordan Axelrad, MD, on IBD and Malignancy
08/19/2024
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr...
08/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use